Literature DB >> 24691986

Continuous sequential boundaries for vaccine safety surveillance.

Rongxia Li1, Brock Stewart, Eric Weintraub, Michael M McNeil.   

Abstract

Various recently developed sequential methods have been used to detect signals for post-marketing surveillance in drug and vaccine safety. Among these, the maximized sequential probability ratio test (MaxSPRT) has been used to detect elevated risks of adverse events following vaccination using large healthcare databases. However, a limitation of MaxSPRT is that it only provides a time-invariant flat boundary. In this study, we propose the use of time-varying boundaries for controlling how type I error is distributed throughout the surveillance period. This is especially useful in two scenarios: (i) when we desire generally larger sample sizes before a signal is generated, for example, when early adopters are not representative of the larger population; and (ii) when it is desired for a signal to be generated as early as possible, for example, when the adverse event is considered rare but serious. We consider four specific time-varying boundaries (which we call critical value functions), and we study their statistical power and average time to signal detection. The methodology we present here can be viewed as a generalization or flexible extension of MaxSPRT. Published 2014. This article is a US Government work and is in the public domain in the USA.

Keywords:  adverse events; critical value; drug and vaccine surveillance; maximized sequential probability ratio test (MaxSPRT); sequential methods

Mesh:

Substances:

Year:  2014        PMID: 24691986     DOI: 10.1002/sim.6161

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Exact conditional maximized sequential probability ratio test adjusted for covariates.

Authors:  Ivair R Silva; Lingling Li; Martin Kulldorff
Journal:  Seq Anal       Date:  2019-05-13       Impact factor: 0.927

2.  Continuous Post-Market Sequential Safety Surveillance with Minimum Events to Signal.

Authors:  Martin Kulldorff; Ivair R Silva
Journal:  Revstat Stat J       Date:  2017-07       Impact factor: 0.985

3.  Vaccine adverse event enrichment tests.

Authors:  Shuoran Li; Lili Zhao
Journal:  Stat Med       Date:  2021-05-09       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.